Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.7 |
mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.02 | 0.7 |
mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.7 |
mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.023 | 0.7 |